Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials
In Brief: Wells, Gardner, Brennan Lead Surgical Oncology; Young, Flynn, Are New officers For Head & Neck
ACCC Statement, ASCO Comments On Health Reform
DCBDC board Okays RFA concept On AIDS Lymphoma
NIH Issues Interim Guidelines For Research Using fetal Tissue
Cancer Meetings Listed
RFP, RFA Available
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science









